Clinical Trial Update: Efficacy of Traumatic Memory Modification Using Memory Reconsolidation and Propranolol Among Adolescents With PTSD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating memory reconsolidation with propranolol for adolescents with post-traumatic stress disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Rennes University Hospital | Conditions: Post Traumatic Stress Disorder | Phase 2 | Status: WITHDRAWN